Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 7/20 | 0.48 |
| ▸ | KCNQ2 | O43526 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.45 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1855552 | 1.00 | MEN1 (0.52) | MEN1KMT2ACDC25BPGRKCNQ2 | |
| SCHEMBL12997896 | 1.00 | MEN1 (0.52) | MEN1KMT2ACDC25BPGRKCNQ2 | |
| SCHEMBL12997894 | 1.00 | MEN1 (0.52) | MEN1KMT2ACDC25BPGRKCNQ2 | |
| SCHEMBL31638323 | 0.86 | PGR (0.46) | MEN1KMT2ACDC25BPGRCYP1A2 | |
| SCHEMBL10048314 | 0.84 | ELANE (0.58) | MEN1KMT2ACDC25BPGRKCNQ2 | |
| SCHEMBL15281144 | 0.84 | ELANE (0.58) | MEN1KMT2APGRKCNQ2PDK2 | |
| SCHEMBL14702110 | 0.84 | PDK2 (0.42) | MEN1KMT2APGRPDK2MAPT | |
| SCHEMBL29363404 | 0.84 | HTR2A (0.48) | MEN1KMT2APGRPDK2PDK4 | |
| SCHEMBL283246 | 0.84 | HTR2A (0.48) | MEN1KMT2APGRPDK2PDK4 | |
| SCHEMBL883417 | 0.83 | DAO (0.43) | MEN1KMT2ACDC25BPGRKCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735495-A | Preparation method of 10, 10-dimethyl anthrone | 四川仁安药业有限责任公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119019315-A | 10, 10-Dimethyl anthrone derivative and organic electroluminescent device thereof | 西安欧得光电材料有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-3943492-B1 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | NOCTILUCA S A (PL) | 2024-05-08 | — | — | EP | claimed |
| CN-117843460-A | Preparation method for producing 10, 10-dimethyl anthrone | 中国科学院大连化学物理研究所 | 2024-04-09 | — | — | CN | claimed |
| CN-117776886-A | Preparation method of melitracen hydrochloride intermediate | 广东赛烽医药科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115417753-B | Synthesis method of melitracen and intermediate thereof | 重庆西南制药二厂有限责任公司 | 2024-01-30 | — | — | CN | claimed |
| CN-114685255-B | Preparation method of melitracen hydrochloride intermediate | 重庆圣华曦药业股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-115417753-A | Synthetic method of melitracen and intermediate thereof | 重庆西南制药二厂有限责任公司 | 2022-12-02 | — | — | CN | claimed |
| CN-114685255-A | Preparation method of melitracen hydrochloride intermediate | 重庆圣华曦药业股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-113105335-B | Synthetic method of stable deuterium-labeled melitracen hydrochloride | 梯尔希（南京）药物研发有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-117776886-B | Preparation method of melitracen hydrochloride intermediate | 广东赛烽医药科技有限公司 | 2026-04-17 | — | — | CN | disclosed |
| CN-117843460-B | Preparation method for producing 10, 10-dimethyl anthrone | 中国科学院大连化学物理研究所 | 2026-04-14 | — | — | CN | disclosed |
| CN-117843460-B | Preparation method for producing 10, 10-dimethyl anthrone | 中国科学院大连化学物理研究所 | 2026-04-14 | — | — | CN | disclosed |
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | SHOEI CHEMICAL INC. (JP) | 2026-03-03 | — | — | US | disclosed |
| CN-120058770-A | Aryl silicon modified spiro organic photoelectric functional material and synthesis method thereof | 河南省科学院化学研究所有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-107840834-B | Benzopyrene compound and application thereof | 北京鼎材科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-109705018-B | Organic compound, organic mixture, composition and organic electronic device | 广州华睿光电材料有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-114685255-A | Preparation method of melitracen hydrochloride intermediate | 重庆圣华曦药业股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685255-A | Preparation method of melitracen hydrochloride intermediate | 重庆圣华曦药业股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-113105335-B | Synthetic method of stable deuterium-labeled melitracen hydrochloride | 梯尔希（南京）药物研发有限公司 | 2022-03-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565613-B2 | Quantum dots with donor-acceptor ligands | HCCS, FDPS, FTH1 | MEN1 4437/4885KMT2A 3820/4885CDC25B 2333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.